Proteomic profile of preeclampsia in the first trimester of pregnancy

References

• Al-Jameil N, Aziz Khan F, Fareed Khan M, et al. A brief overview of preeclampsia. J Clin Med Res. 2013;6(1):1–7.
   PubMedGoogle Scholar
• Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066–1074.
   PubMed Web of Science ®Google Scholar
• Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012;36(1):56–59.
   PubMed Web of Science ®Google Scholar
• Jiménez Cotes E, Martínez Sánchez L, Vargas Grisales N, et al. Preeclampsia: la evolución diagnóstica desde la genómica y la proteómica [Internet]. Vol. 78, Revista chilena de obstetricia y ginecología. Sociedad Chilena de Obstetricia y Ginecología; 2013; [cited 2018 Sep 21]. Available from: https://scielo.conicyt.cl/pdf/rchog/v78n2/art14.pdf
   Google Scholar
• Villaseñor-Hidalgo R, García-Rangel MJ, Ramírez-Zaragoza HF, et al. Aptitud clínica del médico familiar sobre preeclampsia-eclampsia en la unidad de medicina familiar no. 94 del IMSS. Atención Fam. 2017;24:27–31.
   Google Scholar
• Roberts JM, Bell MJ. If we know so much about preeclampsia, why haven't we cured the disease? J Reprod Immunol. 2013;99(1–2):1–9.
   PubMed Web of Science ®Google Scholar
• Gilbert JS, Ryan MJ, LaMarca BB, et al. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Circ Physiol. 2008;294(2):H541–H550.
   PubMed Web of Science ®Google Scholar
• Gathiram P, Moodley J. Pre-eclampsia: its pathogenesis and pathophysiolgy. Cardiovasc J Afr. 2016;27(2):71–78.
   PubMed Web of Science ®Google Scholar
• Redman CWG, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010;63(6):534–543.
   PubMed Web of Science ®Google Scholar
• Harmon AC, Cornelius DC, Amaral LM, et al. The role of inflammation in the pathology of preeclampsia. Clin Sci. 2016;130(6):409–419.
   PubMed Web of Science ®Google Scholar
• Fisher SJ. Why is placentation abnormal in preeclampsia? Am J Obstet Gynecol. 2015;213(4 Suppl.):S115–S122.
   PubMed Web of Science ®Google Scholar
• Valenzuela FJ, Pérez-Sepúlveda A, Torres MJ, et al. Pathogenesis of preeclampsia: the genetic component. J Pregnancy. 2012;2012:1–8.
   Google Scholar
• Moon JY, Moon MH, Kim KT, et al. Cytochrome P450-mediated metabolic alterations in preeclampsia evaluated by quantitative steroid signatures. J Steroid Biochem Mol Biol. 2014;139:182–191.
   PubMed Web of Science ®Google Scholar
• Grotegut CA. Prevention of preeclampsia. J Clin Invest. 2016;126(12):4396–4398.
   PubMed Web of Science ®Google Scholar
• Dahabiyeh LA. The discovery of protein biomarkers in pre-eclampsia: the promising role of mass spectrometry. Biomarkers. 2018;23:1–13.
   PubMed Web of Science ®Google Scholar
• Goetzinger KR, Zhong Y, Cahill AG, et al. Efficiency of first-trimester uterine artery Doppler, a-disintegrin and metalloprotease 12, pregnancy-associated plasma protein a, and maternal characteristics in the prediction of preeclampsia. J Ultrasound Med. 2013;32(9):1593–1600.
   PubMed Web of Science ®Google Scholar
• Brown MA, Magee LA, Kenny LC, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24–43.
   PubMed Web of Science ®Google Scholar
• Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nut Rev. 2013;71(1):1–14.
   PubMedGoogle Scholar
• Walsh SW. Obesity: a risk factor for preeclampsia. Trends Endocrinol Metab. 2007;18(10):365–370.
   PubMed Web of Science ®Google Scholar
• Bodnar LM, Catov JM, Klebanoff MA, et al. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology. 2007;18(2):234–239.
   PubMed Web of Science ®Google Scholar
• Jasovic-Siveska E. Obesity as risk factor for preeclampsia. EC Gynaecol. 2014;1:3–6.
   Google Scholar
• Odegard RA, Vatten LJ, Nilsen ST, et al. Preeclampsia and fetal growth. Obstet Gynecol. 2000;96(6):950–955.
   PubMed Web of Science ®Google Scholar
• Rasmussen S, Irgens LM. Fetal growth and body proportion in preeclampsia. Obstet Gynecol. 2003;101(3):575–583.
   PubMed Web of Science ®Google Scholar
• Enquobahrie DA, Qiu C, Muhie SY, et al. Maternal peripheral blood gene expression in early pregnancy and preeclampsia. Int J Mol Epidemiol Genet. 2011;2(1):78–94.
   PubMedGoogle Scholar
• Jiang M, Lash GE, Zhao X, et al. CircRNA-0004904, CircRNA-0001855, and PAPP-A: potential novel biomarkers for the prediction of preeclampsia. Cell Physiol Biochem. 2018;46(6):2576–2586.
   PubMedGoogle Scholar
• Threadgill DW, Dlugosz AA, Hansen LA, et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. American Association for the Advancement of Science Stable; 2018. Available from: https://www.jstor.org/stable/2888447 JSTOR is a not-for-profit service that helps
   Google Scholar
• Large MJ, Wetendorf M, Lanz RB, et al. The epidermal growth factor receptor critically regulates endometrial function during early pregnancy. PLOS Genet. 2014;10(6):e1004451.
   PubMed Web of Science ®Google Scholar
• Chim SSC, Lee WS, Ting YH, et al. Systematic identification of spontaneous preterm birth-associated RNA transcripts in maternal plasma. PLOS One. 2012;7(4):e34328.
   PubMed Web of Science ®Google Scholar
• Matsuzaki S, Canis M, Darcha C, et al. HOXA-10 expression in the mid-secretory endometrium of infertile patients with either endometriosis, uterine fibromas or unexplained infertility. Hum Reprod. 2009;24(12):3180–3187.
   PubMed Web of Science ®Google Scholar
• Chi L, Ahmed A, Roy AR, Vuong S, et al. G9a controls placental vascular maturation by activating the Notch Pathway. Development. 2017;144(11):1976–1987.
   PubMed Web of Science ®Google Scholar
• Ibarra A, Hetzer MW. Nuclear pore proteins and the control of genome functions. Genes Dev. 2015;29(4):337–349.
   PubMed Web of Science ®Google Scholar
• Guffanti E, Kittur N, Brodt ZN, et al. Nuclear pore complex proteins mark the implantation window in human endometrium. J Cell Sci. 2008;121(Pt 12):2037–2045.
   PubMed Web of Science ®Google Scholar
• Chow K-H, Elgort S, Dasso M, et al. The SUMO proteases SENP1 and SENP2 play a critical role in nucleoporin homeostasis and nuclear pore complex function. Mol Biol Cell. 2014;25(1):160–168.
   PubMed Web of Science ®Google Scholar
• Zhou HJ, Xu Z, Wang Z, et al. SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis. Nat Commun. 2018;9(1):1–16.
   PubMedGoogle Scholar
• Baczyk D, Drewlo S, Kingdom JCP. Emerging role of SUMOylation in placental pathology. Placenta. 2013;34(7):606–612.
   PubMed Web of Science ®Google Scholar
• Small HY, Akehurst C, Sharafetdinova L, et al. HLA gene expression is altered in whole blood and placenta from women who later developed preeclampsia. Physiol Genomics. 2017;49(3):193–200.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Jia L, Zhang L. Polymorphism of HLA-A and HLA-B in pre-eclampsia. Beijing Da Xue Xue Bao. 2009;41(4):418–425.
   PubMedGoogle Scholar
• Teahan C, Rowe P, Parker P, et al. The X-linked chronic granulomatous disease gene codes for the β-chain of cytochrome b-245. Nature. 1987;327(6124):720–721.
   PubMed Web of Science ®Google Scholar
• Ishii N, Fujii M, Hartman PS, et al. A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature. 1998;394(6694):694–697.
   PubMed Web of Science ®Google Scholar
• Redman CWG, Staff AC. Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. Am J Obstet Gynecol. 2015;213(4):S9.e1–S9.e4.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30(Suppl.):32–37.
   PubMedGoogle Scholar
• Bours MJL, Swennen ELR, Di Virgilio F, et al. Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther. 2006;112(2):358–404.
   PubMed Web of Science ®Google Scholar
• Spaans F, De Vos P, Bakker WW, et al. Danger signals from ATP and adenosine in pregnancy and preeclampsia. Hypertension. 2014;63(6):1154–1160.
   PubMed Web of Science ®Google Scholar
• Moriyama T, Nagai M, Oka M, et al. Targeted disruption of one of the importin α family members leads to female functional incompetence in delivery. FEBS J. 2011;278(9):1561–1572.
   PubMed Web of Science ®Google Scholar
• O’Rourke RW, Johnson GS, Purnell JQ, et al. Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes. Int J Obes. 2019;43(2):285–296.
   Web of Science ®Google Scholar
• Nguyen TPH, Patrick CJ, Parry LJ, et al. Using proteomics to advance the search for potential biomarkers for preeclampsia: a systematic review and meta-analysis. PLOS One. 2019;14(4):e0214671.
   PubMed Web of Science ®Google Scholar
• Tarca AL, Romero R, Benshalom-Tirosh N, et al. The prediction of early preeclampsia: results from a longitudinal proteomics study. PLoS One. 2019;14(6):e0217273.
   PubMed Web of Science ®Google Scholar